Ascendis Pharma A/S - ASND
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 09, 2026 | SVP & PAO | M | D | 3,000.0 | 0.0 | 0.0 | 687.0 | View | |
| Sep 09, 2026 | SVP & PAO | S | D | 3,000.0 | 270.19 | 810,570.0 | 0.0 | View | |
| Sep 09, 2026 | SVP & PAO | M | A | 3,000.0 | 110.0 | 330,000.0 | 3,000.0 | View | |
| Sep 03, 2026 | — | S | D | 236.0 | 264.1296 | 62,334.59 | 4,000.0 | View | |
| Aug 18, 2026 | — | P | A | 900.0 | 246.91 | 222,219.0 | 2,900.0 | View | |
| Aug 18, 2026 | — | P | A | 1,100.0 | 245.85 | 270,435.0 | 2,000.0 | View | |
| Jun 02, 2026 | EVP & Chief Financial Officer | P | A | 100.0 | 219.0 | 21,900.0 | 4,367.0 | View | |
| Jun 01, 2026 | — | P | A | 100.0 | 223.5 | 22,350.0 | 900.0 | View | |
| Jun 01, 2026 | — | P | A | 200.0 | 222.3 | 44,460.0 | 800.0 | View | |
| Jun 01, 2026 | — | P | A | 200.0 | 223.76 | 44,752.0 | 600.0 | View | |
| Jun 01, 2026 | EVP & Chief Financial Officer | P | A | 250.0 | 223.32 | 55,830.0 | 4,267.0 | View | |
| May 27, 2026 | — | P | A | 200.0 | 239.3675 | 47,873.5 | 400.0 | View | |
| May 27, 2026 | — | P | A | 200.0 | 236.235 | 47,247.0 | 200.0 | View | |
| May 12, 2026 | See Remarks | S | D | 19,460.0 | 238.4903 | 4,641,021.24 | 0.0 | View |